Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Gain Therapeutics Inc
GANXCurrent price
2.03 USD
-0.07 USD (-3.33%)
Last closed
2.08 USD
Company
www.gaintherapeutics.com
ISIN
US36269B1052
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
56 561 132 USD
Yield for 12 month
-26.98 %
1Y
3Y
5Y
10Y
15Y
GANX
Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. Its drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease. The company's lead drug candidate, GT-02287 for the treatment of GBA1 Parkinson's disease is being evaluated in a Phase I clinical trials. It has various small molecule drug candidates, which are in the discovery, research, and preclinical stages for the treatment of Dementia with Lewy Bodies, Alzhiemer's Disease, Gaucher, GM1 Gangliosidosis, Krabbe Disease, Alpha1-Antitrypsun deficiency, and solid tumors. The company was founded in 2017 and is headquartered in Bethesda, Maryland. Address: 4800 Montgomery Lane, Bethesda, MD, United States, 20814
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7.4 USDP/E ratio
–Dividend Yield
–Current Year
+55 180 USD
Last Year
+140 108 USD
Current Quarter
–
Last Quarter
–
Current Year
-25 202 USD
Last Year
+75 940 USD
Current Quarter
-20 593 USD
Last Quarter
-20 528 USD
Key Figures GANX
1 year
3 years
5 years
10 years
EBITDA
-21 823 828 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-72.96 %
PEG Ratio
–
Return On Equity TTM
-188.83 %
Wall Street Target Price
7.4 USD
Revenue TTM
–
Book Value
0.47 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
-7 660 886 USD
Earnings per share
-1.31 USD
Diluted Eps TTM
-1.31 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics GANX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GANX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation GANX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
138.3348
Price Sales TTM
925.9162
Enterprise Value EBITDA
-1.5489
Price Book MRQ
4.7995
Financials GANX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GANX
For 52 weeks
0.89 USD
5.33 USD
50 Day MA
1.94 USD
Shares Short Prior Month
654 274
200 Day MA
2.52 USD
Short Ratio
1.6
Shares Short
572 006
Short Percent
2.35 %
BeatStart